Michael Canney, Ph.D., is Chief Scientific Officer at Carthera, a clinical-stage medtech company advancing brain therapy through innovative ultrasound-based devices. A co-author of more than 50 peer-reviewed articles, he specializes in neuro-oncology, glioblastoma and neurodegenerative diseases. At Carthera, he is responsible for leading scientific collaborations with academic institutions, organizing U.S. clinical trials and more.
Find Michael at: https://carthera.eu/
Bluesky: https://bsky.app/profile/carthera.bsky.social
LinkedIn: https://www.linkedin.com/company/carthera/
Find more about Brain Wellness at: https://brainwellnesssolutions.com/
Support the show with Buy me a Coffee: https://www.buymeacoffee.com/brainwellnessnp
